Stockscreener 앱 받기
315.20
13.87%
40.79
전일 마감가:
$274.41
열려 있는:
$308.005
하루 거래량:
509.08K
Relative Volume:
0.52
시가총액:
$22.69B
수익:
$3.07B
순이익/손실:
$493.70M
주가수익비율:
46.40
EPS:
6.7935
순현금흐름:
$468.90M
1주 성능:
+15.81%
1개월 성능:
+29.44%
6개월 성능:
+1.70%
1년 성능:
+43.21%
1일 변동 폭
$307.50
$320.33
1주일 범위
$269.98
$320.33
52주 변동 폭
$199.89
$322.34
West Pharmaceutical Services Inc Stock (WST) Company Profile
명칭
West Pharmaceutical Services Inc
전화
(610) 594-2900
주소
530 HERMAN O. WEST DRIVE, EXTON, PA
Compare WST vs ISRG, BDX, MDLN, ALC, RMD
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
WST
West Pharmaceutical Services Inc
|
314.80 | 19.80B | 3.07B | 493.70M | 468.90M | 6.7935 |
ISRG
Intuitive Surgical Inc
|
479.67 | 160.28B | 10.58B | 2.99B | 2.49B | 8.2405 |
BDX
Becton Dickinson Co
|
155.58 | 44.57B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
46.96 | 38.56B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
75.80 | 37.93B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
219.57 | 32.23B | 5.40B | 1.49B | 1.78B | 10.12 |
West Pharmaceutical Services Inc Stock (WST) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-12-02 | 개시 | Morgan Stanley | Equal-Weight |
| 2025-09-15 | 개시 | Rothschild & Co Redburn | Buy |
| 2025-06-24 | 개시 | Barclays | Equal Weight |
| 2025-03-18 | 개시 | Evercore ISI | Outperform |
| 2025-02-14 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2025-01-08 | 개시 | Citigroup | Buy |
| 2024-12-13 | 개시 | Wolfe Research | Peer Perform |
| 2024-12-12 | 업그레이드 | UBS | Neutral → Buy |
| 2024-02-07 | 업그레이드 | Jefferies | Hold → Buy |
| 2023-06-16 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2023-04-11 | 업그레이드 | Stephens | Equal-Weight → Overweight |
| 2022-12-14 | 개시 | Deutsche Bank | Hold |
| 2022-11-30 | 개시 | UBS | Neutral |
| 2022-10-28 | 다운그레이드 | BofA Securities | Buy → Neutral |
| 2020-11-10 | 개시 | KeyBanc Capital Markets | Overweight |
| 2020-10-14 | 개시 | Stephens | Equal-Weight |
| 2020-07-21 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-04-24 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-12-12 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2019-07-26 | 업그레이드 | BofA/Merrill | Underperform → Neutral |
| 2019-05-01 | 다운그레이드 | Jefferies | Buy → Hold |
| 2019-04-23 | 개시 | William Blair | Outperform |
| 2018-04-25 | 다운그레이드 | BofA/Merrill | Neutral → Underperform |
| 2018-01-24 | 개시 | Goldman | Neutral |
| 2017-10-17 | 다운그레이드 | BofA/Merrill | Buy → Neutral |
| 2017-10-03 | 개시 | Stephens | Equal-Weight |
| 2017-09-15 | 업그레이드 | Jefferies | Hold → Buy |
| 2016-10-28 | 업그레이드 | Wells Fargo | Market Perform → Outperform |
| 2016-09-21 | 다운그레이드 | Wells Fargo | Outperform → Market Perform |
| 2016-03-22 | 개시 | Wells Fargo | Outperform |
| 2010-05-14 | 재확인 | UBS | Neutral |
| 2010-02-23 | 개시 | Jefferies & Co | Buy |
| 2008-12-19 | 개시 | UBS | Neutral |
모두보기
West Pharmaceutical Services Inc 주식(WST)의 최신 뉴스
Earnings Flash (WST) West Pharmaceutical Services, Inc. Posts Q1 Adjusted EPS $2.13 per Share, vs. FactSet Est of $1.68 - marketscreener.com
West Reports First-Quarter 2026 Results - PR Newswire
West Pharmaceutical Q1 2026 earnings preview - MSN
West Pharmaceutical earnings loom as GLP-1 exposure in focus By Investing.com - Investing.com Australia
West Pharmaceutical earnings loom as GLP-1 exposure in focus - Investing.com
Earnings To Watch: West Pharmaceutical Services (WST) Reports Q1 Results Tomorrow - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors despite losses on the day - MarketWatch
WST Likely to Beat Q1 Earnings Estimates: How to Play the Stock? - TradingView
Exploring Analyst Estimates for West Pharmaceutical (WST) Q1 Earnings, Beyond Revenue and EPS - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services (WST): Strong Buy Ratings And A Promising 15.98% Upside - DirectorsTalk Interviews
Reasons to retain West Pharmaceutical stock in your portfolio for now - MSN
West Pharmaceutical Services, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics - Markets Mojo
Assessing West Pharmaceutical Services (WST) Valuation After Recent Share Price Momentum - Sahm
Lbp Am Sa Acquires 19,819 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Purchased by Robeco Institutional Asset Management B.V. - MarketBeat
After Plunging 9.7% in 4 Weeks, Here's Why the Trend Might Reverse for West Pharmaceutical (WST) - Eastern Progress
West Pharmaceutical Services to Report Q1 Results April 23 - MyChesCo
Reasons to Retain West Pharmaceutical Stock in Your Portfolio for Now - Zacks Investment Research
West Pharmaceutical Services (WST) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Zacks Research Downgrades West Pharmaceutical Services (NYSE:WST) to Hold - MarketBeat
West Pharmaceutical Services, Inc. $WST Shares Sold by Sumitomo Mitsui Trust Group Inc. - MarketBeat
Border to Coast Pensions Partnership Ltd Has $65.14 Million Stock Position in West Pharmaceutical Services, Inc. $WST - MarketBeat
West Pharmaceutical Services (WST) Projected to Post Earnings on Thursday - MarketBeat
West Pharmaceutical Services Inc (WST) Shares Surge 3.1% -- What GF Score of 93 Tells Investors - GuruFocus
Brendel Financial Advisors LLC Acquires New Holdings in West Pharmaceutical Services, Inc. $WST - MarketBeat
Annex Advisory Services LLC Buys 9,800 Shares of West Pharmaceutical Services, Inc. $WST - MarketBeat
Why West Pharmaceutical Services (WST) is a Top Momentum Stock for the Long-Term - Eastern Progress
Barclays Issues Positive Forecast for West Pharmaceutical Services (NYSE:WST) Stock Price - MarketBeat
Barclays Adjusts Price Target on West Pharmaceutical Services to $275 From $265, Maintains Equalweight Rating - Moomoo
Barclays Maintains West Pharmaceutical Services(WST.US) With Hold Rating, Raises Target Price to $275 - Moomoo
AMI Asset Management Corp Has $43.76 Million Stake in West Pharmaceutical Services, Inc. $WST - MarketBeat
Concerns over pharma in Waterford - waterford-news.ie
Hedge Fund Moves: What are West Pharmaceutical Services Incs growth levers2026 Winners & Losers & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Hedge Fund Moves: Whats the outlook for West Pharmaceutical Services Incs sectorNew Guidance & Safe Entry Momentum Stock Tips - baoquankhu1.vn
WST (West Pharmaceutical Services) Policyholder Funds - GuruFocus
WST (West Pharmaceutical Services) Fees and Other Income - GuruFocus
WST (West Pharmaceutical Services) Inventory Turnover : 1.14 (As of Dec. 2025) - GuruFocus
WST (West Pharmaceutical Services) Earnings Yield (Joel Greenblatt) % : 3.11% (As of Dec. 2025) - GuruFocus
WST (West Pharmaceutical Services) Property, Plant and Equipment : $1,843 Mil (As of Dec. 2025) - GuruFocus
Here's what to expect from West Pharmaceutical's next earnings report - MSN
West Pharmaceutical Services to Release Q1 2026 Financial Results - Intellectia AI
Vial Adapters Market is expected to Hit US$ 1,369.41 Billion - openPR.com
West Pharmaceutical Services to Announce Q1 2026 Financial Results - Intellectia AI
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors - MarketWatch
West to Host First-Quarter 2026 Conference Call - BioSpace
West Pharmaceutical Opens Dublin Expansion to Boost Capacity - MyChesCo
West Pharmaceutical stock: What you should know now before buying - AD HOC NEWS
West Pharmaceutical Services, Inc. (WST) stock price, news, quote and history - Yahoo Finance UK
West Pharmaceutical Services (WST) Stock Analysis: A Steady Healthcare Innovator with 24% Upside Potential - DirectorsTalk Interviews
Stock List: Research Stocks from Around the World - GuruFocus
West Pharmaceutical Services Inc (WST) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.68%
자본화:
|
볼륨(24시간):